The Clorox Company (NYSE:CLX) Holdings Lifted by Toronto Dominion Bank

Toronto Dominion Bank raised its holdings in The Clorox Company (NYSE:CLX - Free Report) by 8.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,744 shares of the company's stock after buying an additional 5,051 shares during the quarter. Toronto Dominion Bank owned approximately 0.05% of Clorox worth $10,710,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Coldstream Capital Management Inc. boosted its holdings in shares of Clorox by 128.5% in the 3rd quarter. Coldstream Capital Management Inc. now owns 3,626 shares of the company's stock valued at $595,000 after purchasing an additional 2,039 shares during the last quarter. Geode Capital Management LLC grew its position in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock valued at $491,713,000 after acquiring an additional 33,970 shares during the period. M&T Bank Corp increased its stake in Clorox by 0.9% during the third quarter. M&T Bank Corp now owns 30,858 shares of the company's stock worth $5,027,000 after acquiring an additional 287 shares during the last quarter. Continuum Advisory LLC raised its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after purchasing an additional 138 shares during the period. Finally, Public Employees Retirement System of Ohio lifted its stake in shares of Clorox by 26.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock valued at $9,736,000 after purchasing an additional 12,428 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently issued reports on CLX. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and lifted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and increased their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. BNP Paribas upgraded Clorox to a "strong sell" rating in a research note on Friday, September 6th. Finally, Barclays increased their target price on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research note on Friday, November 1st. Five equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox currently has an average rating of "Hold" and a consensus target price of $155.00.

Clorox Stock Up 0.2 %

Shares of CLX stock traded up $0.25 during mid-day trading on Friday, reaching $164.90. 753,014 shares of the company were exchanged, compared to its average volume of 1,229,704. The company has a market capitalization of $20.41 billion, a P/E ratio of 57.46, a P/E/G ratio of 3.04 and a beta of 0.42. The business's 50 day simple moving average is $163.77 and its 200 day simple moving average is $151.54. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.49 EPS. Research analysts predict that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. Clorox's dividend payout ratio (DPR) is 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.